Hiroshi Tanaka
Nagaoka Red Cross Hospital(JP)
Publications by Year
Research Areas
Renal Diseases and Glomerulopathies, Lung Cancer Treatments and Mutations, Systemic Lupus Erythematosus Research, interferon and immune responses, Lung Cancer Research Studies
Most-Cited Works
- → Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique, DIRECT(1996)772 cited
- → Loss of Keap1 Function Activates Nrf2 and Provides Advantages for Lung Cancer Cell Growth(2008)621 cited
- → Transcribed enhancers lead waves of coordinated transcription in transitioning mammalian cells(2015)606 cited
- → Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial(2019)601 cited
- → Clinical responses to EGFR-tyrosine kinase inhibitor retreatment in non-small cell lung cancer patients who benefited from prior effective gefitinib therapy: a retrospective analysis(2011)392 cited
- → Alternative splicing of CD44 mRNA by ESRP1 enhances lung colonization of metastatic cancer cell(2012)